NEW YORK (GenomeWeb News) – Hologic this week announced a handful of executive appointments and the impending retirement of its CFO.

The firm said that it has named Eric Compton to the newly-established position of chief operating officer. He will be responsible for overseeing all of the firm's commercial operations in the US, and its global research and development, manufacturing, and service operations. Compton most recently served as worldwide president of Johnson & Johnson's Ortho Clinical Diagnostics business.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: map of human protein interactions, mutant phenotype variability in organisms of the same species from different genetic backgrounds, and more.

Critics call the Fred Hutchinson Cancer Research Center's Gary Gilliland's prediction of cancer cures within 10 years "out of touch with reality" and "irresponsible."

Ivan Oransky discusses the need for reproducibility research at The Conversation.

The San Diego Union-Tribune posts videos from Biocom's Speaker Series with Illumina's Jay Flatley, who discusses Roche's failed hostile takeover bid.